Cargando…

N-Glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression

Our group previously demonstrated that M-protein light chain (LC) glycosylation can be detected on routine MASS-FIX testing. Glycosylation is increased in patients with immunoglobulin light chain amyloidosis (AL) and rarely changes over the course of a patient’s lifetime. To determine the rates of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dispenzieri, Angela, Larson, D.R., Rajkumar, S.V., Kyle, R.A., Kumar, S.K., Kourelis, Taxiarchis, Arendt, Bonnie, Willrcih, Maria, Dasari, Surendra, Murray, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529948/ https://www.ncbi.nlm.nih.gov/pubmed/32594098 http://dx.doi.org/10.1038/s41375-020-0940-8

Ejemplares similares

MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients
por: Mellors, Patrick W., et al.
Publicado: (2021)

Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients
por: Mellors, Patrick W., et al.
Publicado: (2021)

Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Pang, Li, et al.
Publicado: (2021)

Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients
por: Bosseboeuf, Adrien, et al.
Publicado: (2020)

Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
por: Kleinstern, Geffen, et al.
Publicado: (2022)

Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies
por: Kourelis, Taxiarchis V., et al.
Publicado: (2019)

Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients
por: Visram, A., et al.
Publicado: (2021)

Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement
por: Murray, David, et al.
Publicado: (2019)

Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS)
por: Zushi, Yuriko, et al.
Publicado: (2019)

Relapsed multiple myeloma demonstrates distinct patterns of immune microenvironment and malignant cell-mediated immunosuppression
por: Visram, Alissa, et al.
Publicado: (2021)

A Case of Crystalline Keratopathy in Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Koo, Hyun, et al.
Publicado: (2011)

Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
por: Lomas, Oliver C., et al.
Publicado: (2020)

MGUS bone
por: Imataki, Osamu, et al.
Publicado: (2019)

Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method
por: Vachon, Celine M., et al.
Publicado: (2022)

Inheritance in MGUS and MM
por: Pfreundschuh, Michael
Publicado: (2015)

Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners
por: McShane, Charlene M., et al.
Publicado: (2019)

COVID-19 in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS): An Observational Retrospective Study
por: Sgherza, Nicola, et al.
Publicado: (2021)

Non‐cardiac biopsy sites with high frequency of transthyretin amyloidosis
por: Dasari, Surendra, et al.
Publicado: (2020)

Sarcoidosis and Monoclonal Gammopathy of Undetermined Significance (MGUS): A True Association or Just a Coincidence?
por: Hassanein, Mohamed, et al.
Publicado: (2018)

Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6
por: Clay-Gilmour, Alyssa, et al.
Publicado: (2022)

Proteomic profiling of sporadic late‐onset nemaline myopathy
por: Naddaf, Elie, et al.
Publicado: (2022)

A Proteomic Atlas of Cardiac Amyloid Plaques
por: Kourelis, Taxiarchis V., et al.
Publicado: (2020)

Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome
por: Sumekar, Tanjung A., et al.
Publicado: (2011)

An atlas of the bone marrow bone proteome in patients with dysproteinemias
por: Ho, Matthew, et al.
Publicado: (2023)

Two Cases of Heavy Chain MGUS
por: Van Keer, Jan, et al.
Publicado: (2016)

Severe CIDP-MGUS responsive to Rituximab
por: Posa, Andreas, et al.
Publicado: (2020)

Fixed Dosing of Monoclonal Antibodies in Oncology
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2017)

Correlation between markers of bone metabolism and vitamin D levels in patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Lipe, Brea, et al.
Publicado: (2017)

Characteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1
por: Bosseboeuf, Adrien, et al.
Publicado: (2020)

P29: EFFECTS OF VACCINATION ON INCIDENCE AND OUTCOME OF SARS-COV-2 INFECTION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
por: Sgherza, N, et al.
Publicado: (2022)

Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
por: Lamb, Maxine JE, et al.
Publicado: (2021)

Multiple myeloma in a kidney transplanted patient primarily diagnosed with monoclonal gammopathy of unknown significance (MGUS)-related nephropathy
por: Resuli, Marsela, et al.
Publicado: (2013)

Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients
por: Steiner, Normann, et al.
Publicado: (2017)

The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Treglia, Giorgio, et al.
Publicado: (2021)

An atlas of the bone marrow bone proteome in patients with dysproteinemias
por: Ho, Matthew, et al.
Publicado: (2023)

P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
por: Sgherza, N., et al.
Publicado: (2022)

Correction: Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
Publicado: (2022)

Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies
por: Kumar, Shaji, et al.
Publicado: (2019)

Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report
por: Mayne, Elizabeth Sarah, et al.
Publicado: (2018)

Determination of the target of monoclonal immunoglobulins: a novel diagnostic tool for individualized MGUS therapy, and prevention and therapy of smoldering and multiple myeloma
por: Hermouet, Sylvie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k98egi0a0jmdmjshf2u9d9j415